HERB 2.0: an updated database integrating clinical and experimental evidence for traditional Chinese medicine.

Nucleic Acids Res

Key Laboratory of Intelligent Information Processing, Research Center for Ubiquitous Computing Systems, Institute of Computing Technology, Chinese Academy of Sciences, Beijing 100190, China.

Published: January 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Clinical trials and meta-analyses are considered high-level medical evidence with solid credibility. However, such clinical evidence for traditional Chinese medicine (TCM) is scattered, requiring a unified entrance to navigate all available evaluations on TCM therapies under modern standards. Besides, novel experimental evidence has continuously accumulated for TCM since the publication of HERB 1.0. Therefore, we updated the HERB database to integrate four types of evidence for TCM: (i) we curated 8558 clinical trials and 8032 meta-analyses information for TCM and extracted clear clinical conclusions for 1941 clinical trials and 593 meta-analyses with companion supporting papers. (ii) we updated experimental evidence for TCM, increased the number of high-throughput experiments to 2231, and curated references to 6 644. We newly added high-throughput experiments for 376 diseases and evaluated all pairwise similarities among TCM herbs/ingredients/formulae, modern drugs and diseases. (iii) we provide an automatic analyzing interface for users to upload their gene expression profiles and map them to our curated datasets. (iv) we built knowledge graph representations of HERB entities and relationships to retrieve TCM knowledge better. In summary, HERB 2.0 represents rich data type, content, utilization, and visualization improvements to support TCM research and guide modern drug discovery. It is accessible through http://herb.ac.cn/v2 or http://47.92.70.12.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11701625PMC
http://dx.doi.org/10.1093/nar/gkae1037DOI Listing

Publication Analysis

Top Keywords

experimental evidence
12
clinical trials
12
tcm
9
herb updated
8
evidence traditional
8
traditional chinese
8
chinese medicine
8
evidence tcm
8
high-throughput experiments
8
clinical
6

Similar Publications

Nontargeted Screening of Fingermark Residue Using Comprehensive Two-Dimensional Gas Chromatography-Time-of-Flight Mass Spectrometry for Future Use in Forensic Applications.

J Am Soc Mass Spectrom

September 2025

Nontargeted Separations Laboratory, Chemistry Department, William & Mary, Integrated Science Center 1053, 540 Landrum Drive, Williamsburg, Virginia 23188, United States.

Fingerprints are routinely used as evidence in forensic investigations. Fingermarks, any mark left by a donor whether a complete print or not, include sweat and oil excreted by the donor. The chemical components of fingermarks are typically analyzed by gas chromatography-mass spectrometry (GC-MS).

View Article and Find Full Text PDF

Background: Acute viral respiratory infections (AVRIs) rank among the most common causes of hospitalisation worldwide, imposing significant healthcare burdens and driving the development of pharmacological treatments. However, inconsistent outcome reporting across clinical trials limits evidence synthesis and its translation into clinical practice. A core outcome set (COS) for pharmacological treatments in hospitalised adults with AVRIs is essential to standardise trial outcomes and improve research comparability.

View Article and Find Full Text PDF

Background: Current aftercare in breast cancer survivors aims to detect local recurrences or contralateral disease, while the detection of distant metastases has not been a central focus due to a lack of evidence supporting an effect on overall survival. However, the data underpinning these guidelines are mainly from trials of the 1980s/1990s and have not been updated to reflect the significant advancements in diagnostic and therapeutic options that have emerged over the past 40 years. In this trial, the aim is to test whether a liquid biopsy-based detection of (oligo-) metastatic disease at an early pre-symptomatic stage followed by timely treatment can impact overall survival compared to current standard aftercare.

View Article and Find Full Text PDF

Common neural choice signals reflect accumulated evidence, not confidence.

Cereb Cortex

August 2025

Brain and Cognition, KU Leuven, Tiensestraat 102, 3000 Leuven, Belgium.

Centro-parietal electroencephalogram signals (centro-parietal positivity and error positivity) correlate with the reported level of confidence. According to recent computational work these signals reflect evidence which feeds into the computation of confidence, not directly confidence. To test this prediction, we causally manipulated prior beliefs to selectively affect confidence, while leaving objective task performance unaffected.

View Article and Find Full Text PDF

Purpose: This systematic review provides a critical evaluation, synthesis of the existing literature on isotretinoin's effects on craniomaxillofacial bone.

Methods: Following the PRISMA guidelines and registered in PROSPERO, the review was conducted in August 2024 across various databases. Eligible in vivo studies were analysed for their assessment of isotretinoin's effects on craniomaxillofacial bone.

View Article and Find Full Text PDF